93/590/EC: Commission Decision of 5 November 1993 for the… Article 1

Article 1

1. The Community shall purchase five million doses of each of the following strains of foot-and-mouth disease antigen: - A5 European, - A22 Middle East, - O1 Middle East, - O1 European, up to a maximum cost of ECU 4 065 million. 2. The antigen mentioned in paragraph 1 shall be supplied by Rhône-Mérieux, Pirbright Laboratory, Ash Road, Surrey, United Kingdom.

Read the full instrument →

Other provisions in 93/590/EC: Commission Decision of 5 November 1993 for the…

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 1 of 93/590/EC: Commission Decision of 5 November 1993 for the… (LawPlayer, data as of 2026-07-04)

What to look at next

93/590/EC: Commission Decision of 5 November 1993 for the…, full textThe complete text of this law, so you can read this section in contextEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview